Intelligent Bio Solutions Inc. Common Stock

INBSNASDAQUSD
2.45 USD
0.01 (0.41%)AT CLOSE (11:59 AM EDT)
2.45
0.01 (0.20%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
2.45
0.01 (0.20%)
🟢Market: OPEN
Open?$2.43
High?$2.45
Low?$2.24
Prev. Close?$2.46
Volume?115.6K
Avg. Volume?143.4K
VWAP?$2.38
Rel. Volume?0.81x
Bid / Ask
Bid?$2.05 × 100
Ask?$2.79 × 100
Spread?$0.74
Midpoint?$2.42
Valuation & Ratios
Market Cap?5.9M
Shares Out?2.4M
Float?1.6M
Float %?98.9%
P/E Ratio?N/A
P/B Ratio?0.66
EPS?-$4.86
Dividend?0.00%
Ex-Dividend?N/A

Intelligent Bio Solutions Inc. Common Stock (INBS) trades at $2.45 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
Employees
55
Market Cap
5.8M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2020-12-23
Address
135 W 41ST ST,
NEW YORK, NY 10036
Phone: 646-790-5756
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
85
Short Sent.?
43
Piotroski F-Score?3/9Weak
Altman Z-Score?-8.04Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.40%Elevated
Short Interest?149.0K
Days to Cover?1.0
Free Float1.6M
Avg Daily Volume247.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.11Strong
Quick Ratio?1.98Adequate
Cash Ratio?1.49Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.66CHEAP
P/S?
Peers
100
S&P
78
1.50CHEAP
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP
EV/Sales?
S&P
97
-0.25CHEAP
Returns & Efficiency
ROE?
S&P
3
-129.6%WEAK
ROA?
S&P
3
-78.1%WEAK
Cash Flow & Enterprise
FCF?$-11289119
Enterprise Value?$-978263
Fundamentals ratios updated end of day